India started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...

The Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...

An expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successf...

Takeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...

The Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biolog...

Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...

Phase 3 trials are the last phase of clinical trials that a company conducts before it receives approval to market the drug here.

Yesterday, the Philippines government ordered an investigation into the immunisation of more than 7.3 lakh children with the company's deng...

This is the Mumbai-based company’s second collaboration focussed on the mosquito-borne virus, the first being its pact to develop a botanic...

Sun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.

The ICGEB plans a larger vaccine trial on monkeys in America; the full-fledged human trial after that could cost more than Rs 100 crore.

An expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine develope...

Sanofi Pasteur said Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for ...

If cleared, the step may eventually pave the way for Dengvaxia's availability via the wide government distribution system and private chann...

The injection can thwart all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently, according to WHO.

Country Head, Sanofi Pasteur, Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported bur...

The study showed that 87% of Indian adults in trial were positive to dengue at enrolment, confirming the significant endemic nature of the ...